Yi Guo

980 total citations · 1 hit paper
40 papers, 654 citations indexed

About

Yi Guo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yi Guo has authored 40 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Yi Guo's work include MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (4 papers). Yi Guo is often cited by papers focused on MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (4 papers). Yi Guo collaborates with scholars based in China, United States and Netherlands. Yi Guo's co-authors include Hao Zhang, Xiao Xiong, Fuyou Zhou, Sai‐Ching J. Yeung, Lu Wang, Yusheng Lin, Kai Li, Junkuo Li, Dianzheng Zhang and Yuping Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Oncogene.

In The Last Decade

Yi Guo

38 papers receiving 643 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study

2022 145 citations Kai Li, Yusheng Lin et al. Molecular Cancer profile →

Peers

Countries citing papers authored by Yi Guo

Since Specialization

Citations

This map shows the geographic impact of Yi Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Guo more than expected).

Fields of papers citing papers by Yi Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Guo. The network helps show where Yi Guo may publish in the future.

Co-authorship network of co-authors of Yi Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Guo. A scholar is included among the top collaborators of Yi Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Guo. Yi Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy 2025 ·JACC CardioOncology ·(unknown), (unknown), Mustafa M. Ahmed, Stephen E. Kimmel, Karen Daily, Thomas J. George, Carl J. Pepine, Jiang Bian, Dejana Braithwaite, (unknown), Yi Guo	1
2	Assessing the impact of network and station accessibility on station-level rail transit ridership during peak and off-peak hours 2025 ·Transportation Research Part A Policy and Practice ·Yuan Liang, Donggen Wang, Xingang Zhou, (unknown), Yi Guo	0
3	Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data 2023 ·Biomolecules ·Jinghang Jiang, Zhongyuan Chen, Honghong Wang, (unknown), Jie Zheng, Yi Guo, Yonghua Jiang, Zengnan Mo	6
4	Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma 2023 ·Cancer Research ·Zhenyuan Yu, (unknown), Cheng Su, Wenhao Lu, RuiRui Zhang, (unknown), Bingqian Guo, (unknown), Deyun Liu, (unknown), (unknown), Linjian Mo, Yi Guo, Wenyu Feng, Haotian Xu, (unknown), Jiwen Cheng, Aruo Nan, Zengnan Mo	45
5	Study on SOC estimation of lithium battery based on improved AUKF algorithm 2023 ·(unknown), Yi Guo, Yuhang Chen, (unknown)	1
6	Associations of circulation levels of cytokines with birthweight, preterm birth, spontaneous miscarriages, and stillbirth: A Mendelian randomization analysis 2023 ·Frontiers in Genetics ·Honghong Wang, Jinghang Jiang, (unknown), (unknown), Mingli Li, Shengzhu Huang, (unknown), Zhongyuan Chen, Yi Guo, Jie Zheng, Yonghua Jiang, Zengnan Mo	1
7	Targeted demethylation at ZNF154 promotor upregulates ZNF154 expression and inhibits the proliferation and migration of Esophageal Squamous Carcinoma cells 2022 ·Oncogene ·Wenting He, (unknown), Yi Guo, Yuanzhong Wu, Lulu Zhang, (unknown), Ziming Du, Mingbiao Wei, Weijie Zhu, Wanjuan Chen, Jian‐Yong Shao, Guoliang Xu	13
8	Aqueous extract of Artemisia capillaris improves non-alcoholic fatty liver and obesity in mice induced by high-fat diet 2022 ·Frontiers in Pharmacology ·Liang Meng, (unknown), Yi Guo, Yuyi Zhang, Xiao Xiao, (unknown), (unknown), Tianqi Li, Huan Wang, (unknown), Xiaowen Jiang, Wenhui Yu	8
9	A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study breakdown → 2022 ·Molecular Cancer ·Kai Li, Yusheng Lin, Yichen Luo, Xiao Xiong, Lu Wang, (unknown), Junkuo Li, Fuyou Zhou, Yi Guo, Shaobin Chen, Yuping Chen, Dianzheng Zhang, Sai‐Ching J. Yeung, Hao Zhang	145
10	TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer 2022 ·Frontiers in Genetics ·Xiong Zou, Yi Guo, Zengnan Mo	6
11	Correction: Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2/STAT3/SOX2 signaling 2021 ·Oncogene ·Lu Wang, Liang Du, Xiao Xiong, Yusheng Lin, (unknown), Zhimeng Yao, Shuhong Wang, Yi Guo, Yuping Chen, Kyla Geary, Yunlong Pan, Fuyou Zhou, Shegan Gao, Dianzheng Zhang, Sai‐Ching J. Yeung, Hao Zhang	1
12	TC2N: A Novel Vital Oncogene or Tumor Suppressor Gene In Cancers 2021 ·Frontiers in Immunology ·Hanyang Li, Fang He, Chang Li, Shuang Qiu, (unknown), (unknown), (unknown), Zhenxiao Wang, Yi Guo, Jiayin Lv, Zhihui Sun, Tiejun Wang, Bingjin Li	10
13	Chimeric RNA ASTN2-PAPPAas aggravates tumor progression and metastasis in human esophageal cancer 2020 ·Cancer Letters ·Lu Wang, Xiao Xiong, Zhimeng Yao, (unknown), Yusheng Lin, Wan‐Wan Lin, Kai Li, Xiaozheng Xu, Yi Guo, Yuping Chen, Yunlong Pan, Fuyou Zhou, Jun Fan, Yan Chen, Shegan Gao, Sai‐Ching J. Yeung, Hao Zhang	20
14	Genomic characterization of a newly established esophageal squamous cell carcinoma cell line from China and published esophageal squamous cell carcinoma cell lines 2020 ·Cancer Cell International ·Xiang Li, Dongping Tian, Yi Guo, (unknown), (unknown), Wen Deng, Min Su	6
15	Evaluation of Salivary Exosomal Chimeric GOLM1-NAA35 RNA as a Potential Biomarker in Esophageal Carcinoma 2019 ·Clinical Cancer Research ·Yusheng Lin, Hongmei Dong, (unknown), Wan‐Wan Lin, Kai Li, Xiao Xiong, Yi Guo, Fuyou Zhou, Changchun Ma, Yuping Chen, Hongzheng Ren, Haijun Yang, (unknown), Lang Ma, Stephen J. Meltzer, Sai‐Ching J. Yeung, Hao Zhang	79
16	MTA3 Represses Cancer Stemness by Targeting the SOX2OT/SOX2 Axis 2019 ·iScience ·(unknown), Lu Wang, Jinfeng Gan, Zhimeng Yao, Wan‐Wan Lin, Junkuo Li, Yi Guo, Yuping Chen, Fuyou Zhou, Sai‐Ching J. Yeung, Robert P. Coppes, Dianzheng Zhang, Hao Zhang	19
17	The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma 2018 ·Cancer Medicine ·Lu Wang, (unknown), Kai Li, Yi Guo, (unknown), Zhimeng Yao, (unknown), Shujun Li, (unknown), Qing Liu, Yi Jiang, (unknown), Lei Chen, Fuyou Zhou, Hongzheng Ren, (unknown), Dianzheng Zhang, Sai‐Ching J. Yeung, Hao Zhang	11
18	VariantSpark: population scale clustering of genotype information 2015 ·BMC Genomics ·Aidan R. O’Brien, Neil Saunders, Yi Guo, Fabian A. Buske, Rodney J. Scott, Denis C. Bauer	18
19	PSP94, an upstream signaling mediator of prostasin found highly elevated in ovarian cancer 2014 ·Cell Death and Disease ·(unknown), (unknown), (unknown), Bing‐Hua Jiang, Yi Guo, Heimo Riedel, Martin Mueller, Scot C. Remick, (unknown)	9
20	MZF1 possesses a repressively regulatory function in ERCC1 expression 2006 ·Biochemical Pharmacology ·Qing-Wu Yan, Eddie Reed, Xiaosong Zhong, (unknown), Yi Guo, Jing Yu	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact